NYSE: KDMN       Kadmon Holdings Llc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target:-


No recent Headlines for this stock.

Business Background

Kadmon Holdings Inc was established in Delaware in September 2010. The Company is a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics within autoimmune and fibrotic diseases, oncology and genetic diseases. Its product candidates include KD025, Tesevatinab in oncology, Tesevatinab in Polycystic Kidney disease and KD034. It also markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus (HCV) infection. It competes directly with companies that focus on psoriasis, IPF, cGVHD, NSCLC with brain metastases and/or leptomeningeal metastases and PKD, and companies dedicating their resources to novel forms of therapies for these indications.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

5937  4018  1118  776 

Top 10 Active Counters
 MULN 0.141+0.009 
 FRC 15.77+3.59 
 CS 0.968+0.023 
 LYLT 0.2180.00 
 TSLA 197.58+14.33 
 TQQQ 25.88+1.05 
 ISBC 13.87-0.35 
 XLF 31.96+0.79 
 SQQQ 32.74-1.43 
 CISO 0.386+0.156